B Beta Bionics, Inc.: insider trades · United States · SEC (Form 4) Discover the full insider trade history of Beta Bionics, Inc., a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €641.2m. The latest transaction was disclosed on 3 June 2026 (Cession). Among the most active insiders: Feider Stephen. Every trade is openly available.
€776,638
12 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 3 June 2026
All Executives34 Thresholds0 Prospectus0 Other0
Declarations 34 total
▼ Chief Commercial Officer · Executives · 2 Jun 2026
5,329 shares @ US$12.6071 100.0% of flow Common Stock SEC:0002048497-26-000007:0
▼ Chief Product Officer · Executives · 2 Jun 2026
4,378 shares @ US$12.6071 100.0% of flow Common Stock SEC:0002048500-26-000009:0
▼ Chief Financial Officer · Executives · 2 Jun 2026
6,676 shares @ US$12.6071 14.8% of flow Common Stock SEC:0002048588-26-000008:0
▼ President & CEO · Executives · 2 Jun 2026
16,872 shares @ US$12.6071 100.0% of flow Common Stock SEC:0002048593-26-000006:0
▼ Chief Medical Officer · Executives · 2 Jun 2026
4,222 shares @ US$12.6071 100.0% of flow Common Stock SEC:0002051384-26-000006:0
◆ Director · Executives · 21 May 2026
16,965 shares 0Common Stock SEC:0001239312-26-000003:0
◆ Director · Executives · 21 May 2026
16,965 shares 0Common Stock SEC:0001756438-26-000003:0
◆ Director · Executives · 21 May 2026
16,965 shares 0Common Stock SEC:0001235644-26-000008:0
◆ Director · Executives · 21 May 2026
16,965 shares 0Common Stock SEC:0001810701-26-000003:0
▼ Director · Executives · 21 May 2026
1,000 shares @ US$9.95 47.1% of flow Common Stock SEC:0002048466-26-000003:0
◆ Director · Executives · 21 May 2026
16,965 shares 0Common Stock SEC:0002048466-26-000003:1
▼ Director · Executives · 22 May 2026
998 shares @ US$11.21 52.9% of flow Comon Stock SEC:0002048466-26-000003:2
▼ Director · Executives · 21 May 2026
1,998 shares @ US$9.95 100.0% of flow Common Stock SEC:0002048467-26-000003:0
◆ Director · Executives · 21 May 2026
16,965 shares 0Common Stock SEC:0002048467-26-000003:1
◇ Chief Financial Officer · Executives · 3 Oct 2025
4,982 shares @ US$5.10 4.4% of flow Common Stock SEC:0002048588-25-000004:0
▼ Chief Financial Officer · Executives · 3 Oct 2025
3,828 shares @ US$21.5172 14.3% of flow Common Stock SEC:0002048588-25-000004:1
▼ Chief Financial Officer · Executives · 3 Oct 2025
1,154 shares @ US$22.2778 4.5% of flow Common Stock SEC:0002048588-25-000004:2
◇ Chief Financial Officer · Executives · 8 Sept 2025
9,900 shares @ US$5.10 8.7% of flow Common Stock SEC:0001415889-25-023969:0
▼ Chief Financial Officer · Executives · 8 Sept 2025
9,900 shares @ US$21.1264 36.2% of flow Common Stock SEC:0001415889-25-023969:1
◇ Chief Financial Officer · Executives · 22 Aug 2025
4,413 shares @ US$5.10 3.9% of flow Common Stock SEC:0001415889-25-023023:0
▼ Chief Financial Officer · Executives · 22 Aug 2025
4,413 shares @ US$17.014 13.2% of flow Common Stock SEC:0001415889-25-023023:1
◆ Director · Executives · 26 Mar 2025
12,547 shares 0Common Stock SEC:0001415889-25-009123:0
◆ Director · Executives · 15 Mar 2025
11,247 shares 0Common Stock SEC:0001415889-25-008536:0
◆ Director · Executives · 15 Mar 2025
11,247 shares 0Common Stock SEC:0001415889-25-008537:0
◆ Director · Executives · 15 Mar 2025
11,247 shares 0Common Stock SEC:0001415889-25-008533:0
25 of 34 declarations
Load more (9 remaining)